findmyKOL

Jonathan Katz, MD

Enriched profile

Neurologist; Director, ALS Clinic and Neuromuscular Clinic, California Pacific Medical Center · California Pacific Medical Center (Sutter Health)

ORCIDNone on fileNPI↗
✓ Full profile
Region🇺🇸 San Francisco, CA · West · United StatesSpecialtyNeurologyFocusALS
Active KOLLatest publicationNone indexedOnline presenceverified 2026Payments2021–2025NIH fundingNone on fileWhy? →

Jonathan Katz is Neurologist; Director, ALS Clinic and Neuromuscular Clinic, California Pacific Medical Center at California Pacific Medical Center (Sutter Health). ClinicalTrials.gov lists 4 registered studies with this person as an investigator.

Data verified 14 Aug 2026

Overview

Updated 16 Oct 2026

Jonathan S. Katz, MD, is Neurologist at California Pacific Medical Center (Sutter Health), Forbes Norris ALS Research and Treatment Center, San Francisco, CA. The public record shows 152 publications with 7,908 citations (h-index 45), centered on ALS. It also documents an investigator role on 4 registered clinical trials, industry payments reported by 22 companies.

  • Top research focus: ALS
  • 4 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 22 companies

Generated from the cited public record · current as of 16 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
ALS3 trialsMotor Neuron Disease3 trialsAlzheimer's / Dementia1 trialDementia1 trialMuscular Atrophy1 trialMuscular Atrophy, Spinal1 trialFrontotemporal Dementia1 trialAtrophy1 trialProstate Cancer1 trial

Research focus

OpenAlex concept fingerprint
ALS

Drugs & molecules

across trials, industry payments and publications
Gamunex-CClinical trials—Industry payments43Publications—Radicava ORSClinical trials—Industry payments17Publications—Radicavageneric · EdaravoneClinical trials—Industry payments14Publications—Vyvgartgeneric · Efgartigimod alfaClinical trials—Industry payments11Publications—Spinrazageneric · NusinersenClinical trials—Industry payments8Publications—Vyvgart Hytrulogeneric · Efgartigimod alfa / hyaluronidaseClinical trials—Industry payments8Publications—Xembifygeneric · Immunoglobulin GClinical trials—Industry payments8Publications—Ultomirisgeneric · RavulizumabClinical trials—Industry payments7Publications—Amvuttrageneric · VutrisiranClinical trials—Industry payments6Publications—Exservangeneric · RiluzoleClinical trials—Industry payments5Publications—Relyvriogeneric · Phenylbutyrate / taurursodiolClinical trials—Industry payments5Publications—Upliznageneric · InebilizumabClinical trials—Industry payments3Publications—

Works with

trial sponsors and companies reporting payments
Grifols USA, LLCClinical trials—Industry payments49Argenx Us, Inc.Clinical trials—Industry payments21Mitsubishi Tanabe Pharma America, Inc.Clinical trials—Industry payments19Biogen, Inc.Clinical trials—Industry payments13UCB, Inc.Clinical trials—Industry payments11Alexion Pharmaceuticals, Inc.Clinical trials—Industry payments9Alnylam Pharmaceuticals Inc.Clinical trials—Industry payments8Amylyx Pharmaceuticals, Inc.Clinical trials—Industry payments5Amgen Inc.Clinical trials—Industry payments3Grifols Shared Services North America, Inc.Clinical trials—Industry payments3Janssen Research & Development, LLCClinical trials—Industry payments3Johnson & Johnson Health Care Systems Inc.Clinical trials—Industry payments3PTC Therapeutics, Inc.Clinical trials—Industry payments3Tanabe Pharma America, Inc.Clinical trials—Industry payments3AstraZeneca Pharmaceuticals LPClinical trials—Industry payments2Pfizer Inc.Clinical trials—Industry payments2SK Life Science, Inc.Clinical trials—Industry payments2Teva Pharmaceuticals USA, Inc.Clinical trials—Industry payments2Barrow Neurological InstituteClinical trials1Industry payments—Baxter HealthcareClinical trials—Industry payments1Genzyme CorporationClinical trials—Industry payments1Neuraltus Pharmaceuticals, Inc.Clinical trials1Industry payments—Novavax IncClinical trials—Industry payments1Takeda Pharmaceuticals U.S.A., Inc.Clinical trials—Industry payments1University of MiamiClinical trials1Industry payments—University of Southern CaliforniaClinical trials1Industry payments—

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
45h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
4clinical trials

Investigator role on registered studies.

View trials ↓
22companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
0NIH grants

Federally funded research awards.

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 16 Oct 2026

Listed as an investigator on 4 registered studies on ClinicalTrials.gov. The most recent:

All 4 trial records: search, sort and filter.Explore →

Industry payments

Updated 16 Oct 2026

22 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

All 50 payment records: search, sort and filter.Explore →
View the CMS Open Payments record ↗

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Nervous system

    69.7%
    Other nervous system drugs19.9%
    Radicava Ors100%
    Part D≥20 patients
    Gabapentinoids18%
    Gabapentin89%Pregabalin11%
    Part D<11 patients

    + 6 more classes in this area

  • Metabolism & gastrointestinal

    14%
    Corticosteroid12.2%
    Prednisone100%
    Part D≥18 patients
    Anticholinergic1.9%
    Atropine Sulfate100%
    Part D<11 patients

  • Cancer & immunology

    5.7%
    Purine Antimetabolite5.7%
    Azathioprine100%
    Part D≥12 patients
All 6 therapeutic areas: search, sort and filter.Explore →
Where care is delivered (Part B)3.1% facility · 96.9% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →

Publications

None on file yet. We only list publications we can confidently match to this person. Why? →

Online presence

Updated 16 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/jonathan-katz-md-875aa626

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗

Mentions by others

where others cite or feature them
  • Other

    gbs-cidp.org/gbs_cfe/san-francisco-ca-california-pacific-medical-center

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →gbs-cidp.org ↗
  • Doximity

    Doximity professional profile

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 16 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • M.D.

    Tulane University School of Medicine

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →sutterhealth.org ↗
  • Residency

    Neurology, University of Washington School of Medicine

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →sutterhealth.org ↗
  • Fellowship

    University of Texas Southwestern Medical School

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →sutterhealth.org ↗
  • Board Certified

    Neurology

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →sutterhealth.org ↗

Editorial & leadership roles

journal and society appointments
  • President

    ALS Research Group (international ALS research collaboration)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →sutterhealth.org ↗
  • Medical Advisory Board member

    GBS-CIDP Foundation International

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →gbs-cidp.org ↗
  • Medical Advisory Board member

    Myasthenia Gravis Association

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →sutterhealth.org ↗

Secondary affiliations

appointments beyond the home institution

Media & interviews

press, podcasts and appearances
  • Faculty member

    Decera Clinical Education (CME faculty profile)

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →clinicaloptions.com ↗

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.